Expenses have already been flagged (2.3mil), so this shouldn't really shock the market. Just the cost of getting FDA approval, but it will be nice when CYC can actually bank some of it's high margin business rather than report losses due to FDA costs.
If CYC can get FDA approval and settle its litigation in Germany (expected in the next 12 months) with a nice payout, they should be kicking goals.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)